Eric R. Blough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eric R. Blough has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Kevin M. Rice
Center for Diagnostic Nanosystems, Marshall University, Huntington, WV, USA
37 shared publications Anjaiah Katta
Department of Pharmacology, Physiology and Toxicology, Marshall University, Joan C. Edwards School of Medicine, Huntington, WV 25755-1090, USA
14 shared publicationsMiaozong Wu
Center for Diagnostic Nanosystems, Marshall University, Huntington, WV, USA
14 shared publicationsSatyanarayana Paturi
Center for Diagnostic Nanosystems, Marshall University, Huntington, WV 25755, USA
12 shared publicationsSunil K. Kakarla
11 shared publicationsRavikumar Arvapalli
Center for Diagnostic Nanosystems, Marshall University, Huntington, WV, USA
9 shared publications
Latest Publications
- 1 February 2021
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 85 (2) , 8422
Confronting the “Brutal Facts” and Identifying Opportunities as Pharmacy Education Weathers the COVID-19 Pandemic
The COVID-19 pandemic has caused almost a million deaths worldwide and widespread economic and social strife that has impacted almost every facet of modern life. While contemplating how we might emerge from this pandemic, we were reminded of the Stockdale paradox. We suggest that the Academy must not only confront the brutal facts of the current situation but that we must also maintain faith in the endgame and a commitment to prevail, despite the enormous challenges that may be present. The Academy can play a key role in helping the world recover from this pandemic if we build on the diversity and strengths of our programs nationally and globally. We suggest that there are three key components that pharmacists and pharmacy educators can pursue to show leadership in this time of need. Firstly, we must be the voice that reassures the public about the value of science and the scientific method. Secondly, we need to work locally and nationally to ensure an optimal public health response. Finally, the Academy must serve as role models and leaders with respect to the essential public health tools to prevent the spread of COVID-19. By remaining positive, keeping the endgame in mind, and confronting the most brutal facts of the current COVID-19 pandemic, we are confident that pharmacy education and pharmacy will weather this storm and arise even stronger for it.
- 1 February 2021
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 85 (2) , 8422
Confronting the “Brutal Facts” and Identifying Opportunities as Pharmacy Education Weathers the COVID-19 Pandemic
The COVID-19 pandemic has caused almost a million deaths worldwide and widespread economic and social strife that has impacted almost every facet of modern life. While contemplating how we might emerge from this pandemic, we were reminded of the Stockdale paradox. We suggest that the Academy must not only confront the brutal facts of the current situation but that we must also maintain faith in the endgame and a commitment to prevail, despite the enormous challenges that may be present. The Academy can play a key role in helping the world recover from this pandemic if we build on the diversity and strengths of our programs nationally and globally. We suggest that there are three key components that pharmacists and pharmacy educators can pursue to show leadership in this time of need. Firstly, we must be the voice that reassures the public about the value of science and the scientific method. Secondly, we need to work locally and nationally to ensure an optimal public health response. Finally, the Academy must serve as role models and leaders with respect to the essential public health tools to prevent the spread of COVID-19. By remaining positive, keeping the endgame in mind, and confronting the most brutal facts of the current COVID-19 pandemic, we are confident that pharmacy education and pharmacy will weather this storm and arise even stronger for it.
- Open Access
- 24 October 2015
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 13 (1) , 1-11
Cerium oxide nanoparticles attenuate acute kidney injury induced by intra-abdominal infection in Sprague–Dawley rats
Intra-abdominal infection or peritonitis is a cause for great concern due to high mortality rates. The prognosis of severe intra-abdominal infection is significantly diminished in the presence of acute kidney injury (AKI) which is often characterized by renal tubular cell death that can lead to renal failure. The purpose of the current study is to examine the therapeutic efficacy of cerium oxide (CeO2) nanoparticles for the treatment of peritonitis-induced AKI by polymicrobial insult. A one-time administration of CeO2 nanoparticles (0.5 mg/kg) in the absence of antibiotics or other supportive care, attenuated peritonitis-induced tubular dilatation and the loss of brush border in male Sprague–Dawley rats. These improvements in renal structure were accompanied by decreases in serum cystatin-C levels, reduced renal oxidative stress, diminished Stat-3 phosphorylation and an attenuation of caspase-3 cleavage suggesting that the nanoparticle treatment improved renal glomerular filtration rate, diminished renal inflammation and reduced renal apoptosis. Consistent with these data, further analysis demonstrated that the CeO2 nanoparticle treatment diminished peritonitis-induced increases in serum kidney injury molecule-1 (KIM-1), osteopontin, β-2 microglobulin and vascular endothelial growth factor-A (VEGF-A) levels. In addition, the nanoparticle attenuated peritonitis-induced hyperglycemia along with increases in blood urea nitrogen (BUN), serum potassium and sodium. CeO2 nanoparticles scavenge reactive oxygen species and attenuate polymicrobial insult induced increase in inflammatory mediators and subsequent AKI. Taken together, the data indicate that CeO2 nanoparticles may be useful as an alternative therapeutic agent or in conjunction with standard medical care for the treatment of peritonitis induced acute kidney injury.
- 24 October 2015
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 13 (1) , 1-11
Open AccessCerium oxide nanoparticles attenuate acute kidney injury induced by intra-abdominal infection in Sprague–Dawley rats
Intra-abdominal infection or peritonitis is a cause for great concern due to high mortality rates. The prognosis of severe intra-abdominal infection is significantly diminished in the presence of acute kidney injury (AKI) which is often characterized by renal tubular cell death that can lead to renal failure. The purpose of the current study is to examine the therapeutic efficacy of cerium oxide (CeO2) nanoparticles for the treatment of peritonitis-induced AKI by polymicrobial insult. A one-time administration of CeO2 nanoparticles (0.5 mg/kg) in the absence of antibiotics or other supportive care, attenuated peritonitis-induced tubular dilatation and the loss of brush border in male Sprague–Dawley rats. These improvements in renal structure were accompanied by decreases in serum cystatin-C levels, reduced renal oxidative stress, diminished Stat-3 phosphorylation and an attenuation of caspase-3 cleavage suggesting that the nanoparticle treatment improved renal glomerular filtration rate, diminished renal inflammation and reduced renal apoptosis. Consistent with these data, further analysis demonstrated that the CeO2 nanoparticle treatment diminished peritonitis-induced increases in serum kidney injury molecule-1 (KIM-1), osteopontin, β-2 microglobulin and vascular endothelial growth factor-A (VEGF-A) levels. In addition, the nanoparticle attenuated peritonitis-induced hyperglycemia along with increases in blood urea nitrogen (BUN), serum potassium and sodium. CeO2 nanoparticles scavenge reactive oxygen species and attenuate polymicrobial insult induced increase in inflammatory mediators and subsequent AKI. Taken together, the data indicate that CeO2 nanoparticles may be useful as an alternative therapeutic agent or in conjunction with standard medical care for the treatment of peritonitis induced acute kidney injury.
- Open Access
- 1 September 2015
- Published by Elsevier in Data in Brief
- Vol. 4, 96-99
Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticles
- 1 September 2015
- Published by Elsevier in Data in Brief
- Vol. 4, 96-99
Open AccessLipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticles
- Open Access
- 1 September 2015
- Published by Elsevier in Data in Brief
- Vol. 4, 105-115
Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis
- 1 September 2015
- Published by Elsevier in Data in Brief
- Vol. 4, 105-115
Open AccessCerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis
- 1 August 2015
- Published by Elsevier in Biomaterials
- Vol. 59, 160-171
Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles
- 1 August 2015
- Published by Elsevier in Biomaterials
- Vol. 59, 160-171
Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles
- 1 April 2015
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 81, 47-57
Acetaminophen attenuates glomerulosclerosis in obese Zucker rats via reactive oxygen species/p38MAPK signaling pathways
- 1 April 2015
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 81, 47-57
Acetaminophen attenuates glomerulosclerosis in obese Zucker rats via reactive oxygen species/p38MAPK signaling pathways
- Open Access
- 1 January 2015
- Published by SAGE Publications in Sage Open Medicine
- Vol. 3
Cerium oxide nanoparticle aggregates affect stress response and function in Caenorhabditis elegans
Objective: The continual increase in production and disposal of nanomaterials raises concerns regarding the safety of nanoparticles on the environmental and human health. Recent studies suggest that cerium oxide (CeO2) nanoparticles may possess both harmful and beneficial effects on biological processes. The primary objective of this study is to evaluate how exposure to different concentrations (0.17–17.21 µg/mL) of aggregated CeO2 nanoparticles affects indices of whole animal stress and survivability in Caenorhabditis elegans. Methods: Caenorhabditis elegans were exposed to different concentrations of CeO2 nanoparticles and evaluated. Results: Our findings demonstrate that chronic exposure of CeO2 nanoparticle aggregates is associated with increased levels of reactive oxygen species and heat shock stress response (HSP-4) in Caenorhabditis elegans, but not mortality. Conversely, CeO2 aggregates promoted strain-dependent decreases in animal fertility, a decline in stress resistance as measured by thermotolerance, and shortened worm length. Conclusion: The data obtained from this study reveal the sublethal toxic effects of CeO2 nanoparticle aggregates in Caenorhabditis elegans and contribute to our understanding of how exposure to CeO2 may affect the environment.
- 1 January 2015
- Published by SAGE Publications in Sage Open Medicine
- Vol. 3
Open AccessCerium oxide nanoparticle aggregates affect stress response and function in Caenorhabditis elegans
Objective: The continual increase in production and disposal of nanomaterials raises concerns regarding the safety of nanoparticles on the environmental and human health. Recent studies suggest that cerium oxide (CeO2) nanoparticles may possess both harmful and beneficial effects on biological processes. The primary objective of this study is to evaluate how exposure to different concentrations (0.17–17.21 µg/mL) of aggregated CeO2 nanoparticles affects indices of whole animal stress and survivability in Caenorhabditis elegans. Methods: Caenorhabditis elegans were exposed to different concentrations of CeO2 nanoparticles and evaluated. Results: Our findings demonstrate that chronic exposure of CeO2 nanoparticle aggregates is associated with increased levels of reactive oxygen species and heat shock stress response (HSP-4) in Caenorhabditis elegans, but not mortality. Conversely, CeO2 aggregates promoted strain-dependent decreases in animal fertility, a decline in stress resistance as measured by thermotolerance, and shortened worm length. Conclusion: The data obtained from this study reveal the sublethal toxic effects of CeO2 nanoparticle aggregates in Caenorhabditis elegans and contribute to our understanding of how exposure to CeO2 may affect the environment.
- 1 December 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (37) , 9951-9962
Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension
- 1 December 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (37) , 9951-9962
Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension
- 1 April 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 116, 687-694
Plasma treatment of PDMS for applications of in vitro motility assays
- 1 April 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 116, 687-694
Plasma treatment of PDMS for applications of in vitro motility assays
- Top Cited PapersOpen Access
- 31 March 2014
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 47 (2) , 74-83
Environmental Mercury and Its Toxic Effects
Mercury exists naturally and as a man-made contaminant. The release of processed mercury can lead to a progressive increase in the amount of atmospheric mercury, which enters the atmospheric-soil-water distribution cycles where it can remain in circulation for years. Mercury poisoning is the result of exposure to mercury or mercury compounds resulting in various toxic effects depend on its chemical form and route of exposure. The major route of human exposure to methylmercury (MeHg) is largely through eating contaminated fish, seafood, and wildlife which have been exposed to mercury through ingestion of contaminated lower organisms. MeHg toxicity is associated with nervous system damage in adults and impaired neurological development in infants and children. Ingested mercury may undergo bioaccumulation leading to progressive increases in body burdens. This review addresses the systemic pathophysiology of individual organ systems associated with mercury poisoning. Mercury has profound cellular, cardiovascular, hematological, pulmonary, renal, immunological, neurological, endocrine, reproductive, and embryonic toxicological effects.
- 31 March 2014
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 47 (2) , 74-83
Top Cited PapersOpen AccessEnvironmental Mercury and Its Toxic Effects
Mercury exists naturally and as a man-made contaminant. The release of processed mercury can lead to a progressive increase in the amount of atmospheric mercury, which enters the atmospheric-soil-water distribution cycles where it can remain in circulation for years. Mercury poisoning is the result of exposure to mercury or mercury compounds resulting in various toxic effects depend on its chemical form and route of exposure. The major route of human exposure to methylmercury (MeHg) is largely through eating contaminated fish, seafood, and wildlife which have been exposed to mercury through ingestion of contaminated lower organisms. MeHg toxicity is associated with nervous system damage in adults and impaired neurological development in infants and children. Ingested mercury may undergo bioaccumulation leading to progressive increases in body burdens. This review addresses the systemic pathophysiology of individual organ systems associated with mercury poisoning. Mercury has profound cellular, cardiovascular, hematological, pulmonary, renal, immunological, neurological, endocrine, reproductive, and embryonic toxicological effects.